Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17


A prospective analysis of circulating plasma metabolites associated with ovarian cancer risk.

Zeleznik OA, Eliassen AH, Kraft P, Poole EM, Rosner BA, Jeanfavre S, Deik AA, Bullock K, Hitchcock DS, Avila-Pacheco J, Clish CB, Tworoger SS.

Cancer Res. 2020 Jan 22. pii: canres.2567.2019. doi: 10.1158/0008-5472.CAN-19-2567. [Epub ahead of print]


Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: a 23-year Prospective Study.

Zeleznik OA, Clish CB, Kraft P, Avila-Pancheco J, Eliassen AH, Tworoger SS.

J Natl Cancer Inst. 2019 Oct 8. pii: djz195. doi: 10.1093/jnci/djz195. [Epub ahead of print]


Metabolome-Wide Association Study of the Relationship Between Habitual Physical Activity and Plasma Metabolite Levels.

Ding M, Zeleznik OA, Guasch-Ferre M, Hu J, Lasky-Su J, Lee IM, Jackson RD, Shadyab AH, LaMonte MJ, Clish C, Eliassen AH, Sacks F, Willett WC, Hu FB, Rexrode KM, Kraft P.

Am J Epidemiol. 2019 Nov 1;188(11):1932-1943. doi: 10.1093/aje/kwz171.


Metabolomics Analytics Workflow for Epidemiological Research: Perspectives from the Consortium of Metabolomics Studies (COMETS).

Playdon MC, Joshi AD, Tabung FK, Cheng S, Henglin M, Kim A, Lin T, van Roekel EH, Huang J, Krumsiek J, Wang Y, Mathé E, Temprosa M, Moore S, Chawes B, Eliassen AH, Gsur A, Gunter MJ, Harada S, Langenberg C, Oresic M, Perng W, Seow WJ, Zeleznik OA.

Metabolites. 2019 Jul 17;9(7). pii: E145. doi: 10.3390/metabo9070145.


Integration of Metabolomic and Other Omics Data in Population-Based Study Designs: An Epidemiological Perspective.

Chu SH, Huang M, Kelly RS, Benedetti E, Siddiqui JK, Zeleznik OA, Pereira A, Herrington D, Wheelock CE, Krumsiek J, McGeachie M, Moore SC, Kraft P, Mathé E, Lasky-Su J; Consortium of Metabolomics Studies Statistics Working Group.

Metabolites. 2019 Jun 18;9(6). pii: E117. doi: 10.3390/metabo9060117. Review.


Identification of Plasma Lipid Metabolites Associated with Nut Consumption in US Men and Women.

Malik VS, Guasch-Ferre M, Hu FB, Townsend MK, Zeleznik OA, Eliassen AH, Tworoger SS, Karlson EW, Costenbader KH, Ascherio A, Wilson KM, Mucci LA, Giovannucci EL, Fuchs CS, Bao Y.

J Nutr. 2019 Jul 1;149(7):1215-1221. doi: 10.1093/jn/nxz048.


Metabolomics in epidemiologic research: challenges and opportunities for early-career epidemiologists.

van Roekel EH, Loftfield E, Kelly RS, Zeleznik OA, Zanetti KA.

Metabolomics. 2019 Jan 7;15(1):9. doi: 10.1007/s11306-018-1468-z. Review.


Metabolites Associated With the Risk of Incident Venous Thromboembolism: A Metabolomic Analysis.

Jiang X, Zeleznik OA, Lindström S, Lasky-Su J, Hagan K, Clish CB, Eliassen AH, Kraft P, Kabrhel C.

J Am Heart Assoc. 2018 Nov 20;7(22):e010317. doi: 10.1161/JAHA.118.010317.


A Network Analysis of Biomarkers for Type 2 Diabetes.

Huang T, Glass K, Zeleznik OA, Kang JH, Ivey KL, Sonawane AR, Birmann BM, Hersh CP, Hu FB, Tworoger SS.

Diabetes. 2019 Feb;68(2):281-290. doi: 10.2337/db18-0892. Epub 2018 Nov 8.


Habitual sleep quality, plasma metabolites and risk of coronary heart disease in post-menopausal women.

Huang T, Zeleznik OA, Poole EM, Clish CB, Deik AA, Scott JM, Vetter C, Schernhammer ES, Brunner R, Hale L, Manson JE, Hu FB, Redline S, Tworoger SS, Rexrode KM.

Int J Epidemiol. 2019 Aug 1;48(4):1262-1274. doi: 10.1093/ije/dyy234.


Comparison and evaluation of integrative methods for the analysis of multilevel omics data: a study based on simulated and experimental cancer data.

Pucher BM, Zeleznik OA, Thallinger GG.

Brief Bioinform. 2019 Mar 25;20(2):671-681. doi: 10.1093/bib/bby027.


Obesity-Related Metabolomic Profiles and Discrimination of Metabolically Unhealthy Obesity.

Bagheri M, Farzadfar F, Qi L, Yekaninejad MS, Chamari M, Zeleznik OA, Kalantar Z, Ebrahimi Z, Sheidaie A, Koletzko B, Uhl O, Djazayery A.

J Proteome Res. 2018 Apr 6;17(4):1452-1462. doi: 10.1021/acs.jproteome.7b00802. Epub 2018 Mar 22.


Using Metabolomics to Explore the Role of Postmenopausal Adiposity in Breast Cancer Risk.

Lasky-Su JA, Zeleznik OA, Eliassen AH.

J Natl Cancer Inst. 2018 Jun 1;110(6):547-548. doi: 10.1093/jnci/djx283. No abstract available.


Metabolomic analysis of 92 pulmonary embolism patients from a nested case-control study identifies metabolites associated with adverse clinical outcomes.

Zeleznik OA, Poole EM, Lindstrom S, Kraft P, Van Hylckama Vlieg A, Lasky-Su JA, Harrington LB, Hagan K, Kim J, Parry BA, Giordano N, Kabrhel C.

J Thromb Haemost. 2018 Mar;16(3):500-507. doi: 10.1111/jth.13937. Epub 2018 Jan 30.


Deciphering lipid structures based on platform-independent decision rules.

Hartler J, Triebl A, Ziegl A, Trötzmüller M, Rechberger GN, Zeleznik OA, Zierler KA, Torta F, Cazenave-Gassiot A, Wenk MR, Fauland A, Wheelock CE, Armando AM, Quehenberger O, Zhang Q, Wakelam MJO, Haemmerle G, Spener F, Köfeler HC, Thallinger GG.

Nat Methods. 2017 Dec;14(12):1171-1174. doi: 10.1038/nmeth.4470. Epub 2017 Oct 23.


Molecular Profiling of Phagocytic Immune Cells in Anopheles gambiae Reveals Integral Roles for Hemocytes in Mosquito Innate Immunity.

Smith RC, King JG, Tao D, Zeleznik OA, Brando C, Thallinger GG, Dinglasan RR.

Mol Cell Proteomics. 2016 Nov;15(11):3373-3387. Epub 2016 Sep 13.


Dimension reduction techniques for the integrative analysis of multi-omics data.

Meng C, Zeleznik OA, Thallinger GG, Kuster B, Gholami AM, Culhane AC.

Brief Bioinform. 2016 Jul;17(4):628-41. doi: 10.1093/bib/bbv108. Epub 2016 Mar 11. Review.

Supplemental Content

Loading ...
Support Center